CONCLUSION
Administration of MgSO4 to preeclampsia patients has proven beneficial for the mother
and her fetus. But it is necessary to carry out monitoring in the provision of therapy. Besides
being beneficial for the mother, it is also beneficial for the fetus as a neuroprotector in the fetus.
REFERENCES
Akbar, M. I. A., Yoseph, D., Aditiawarman, Bachnas, M. A., Dachlan, E. G., Dekker, G. A.,
& Ernawati. (2020). Magnesium intoxication in women with preeclampsia with severe
features treated with magnesium sulfate. Hypertension in Pregnancy, 39(3), 221–227.
https://doi.org/10.1080/10641955.2020.1754851
Akbar, M. I., & Putri, G. T. (2021). Terapi Farmakologis Preeklampsia pada Ibu Hamil
Pharmacologic Therapy of Preeclampsia in Pregnant Women. J Agromedicine Unila,
xx(2).
Amalia F. Effect of using MgSO4 as seizure prevention therapy in preeclampsia. J Ilmu
kedokteran dan Kesehatan.2020;7(1):393-400.
Biomedika, J., Surjadi, L. M., Dasuki, D., & Belakang, L. (2019). Perbandingan kadar
magnesium serum setelah terapi magnesium sulfat rute berbeda pada preeklampsia. 2(3),
92–98. https://doi.org/10.18051/JBiomedKes.2019.v2.92-98
Euser, A. G., & Cipolla, M. J. (2009). Go Red for Women Magnesium Sulfate for the Treatment
of Eclampsia A Brief Review. 1169–1175.
https://doi.org/10.1161/STROKEAHA.108.527788
Fox, R., Kitt, J., Leeson, P., Aye, C. Y. L., & Lewandowski, A. J. (2019). Preeclampsia: Risk
factors, diagnosis, management, and the cardiovascular impact on the offspring. Journal
of Clinical Medicine, 8(10), 1–22. https://doi.org/10.3390/jcm8101625
Olda, A. J., Trixie, J. A., Bolang, G. F. Y., Witular, Y. R., & Langi, S. L. F. C. (2022).
Nifedipine, Calcium Channel Blocker (Antihypertensive), as a Tocolytic to inhibit
Premature Birth in Reducing the Risk of Neonatal Death in Childbirth: Meta-Analysis and
Systematic Review of Large Clinical Trial. Indonesian Journal of Obstetrics and
Gynecology, 10(1), 58–62. https://doi.org/10.32771/INAJOG.V10I1.1549
Padda, J., Khalid, K., Colaco, L. B., Padda, S., Boddeti, N. L., Khan, S., Cooper, A. C., & Jean-
charles, G. (2021). Efficacy of Magnesium Sulfate on Maternal Mortality in Eclampsia.
13(8). https://doi.org/10.7759/cureus.17322
Polypharmacy, A. (2020). Magnesium Sulfate - Management of Hypertensive Disorders of
Pregnancy Magnesium Sulfate - Management of Hypertensive Disorders of Pregnancy
Side effects : 1–7.
Rahman, Z., & Helali, A. M. (2014). Facts about Magnesium Sulfate : Time to Revise the Safety
Concern in Obstetric Use. 4(3).
Richter, A. E., Scherjon, S. A., Dikkers, R., Bos, A. F., & Kooi, E. M. W. (2020). Antenatal
Magnesium Sulfate and Preeclampsia Differentially Affect Neonatal Cerebral
Oxygenation. Neonatology, 117(3), 331–340. https://doi.org/10.1159/000507705
Suleman, D. M., Nurdin, A., & Setiawati, D. (2021). Preeclampsia-Eclampsia Gravidarum and
the Delivery of the Cesarean Section Method. Journal of Widya Medika Junior, 3(4), 252–
257. https://doi.org/10.33508/jwmj.v3i4.3507
Tsabitah, K., Wicaksono, B., & Handayani, S. (2020). ORIGINAL ARTICLE : Severe
preeclampsia leads to higher prevalence of mortality and morbidity affecting maternal
outcomes in single tertiary hospital. 28(3), 99–103.
Verschueren, K. J. C., Paidin, R. R., Broekhuis, A., Ramkhelawan, O. S. S., Kodan, L. R.,
Kanhai, H. H. H., Browne, J. L., Bloemenkamp, K. W. M., & Rijken, M. J. (2020). Why